Loading clinical trials...
Loading clinical trials...
Multi-center Phase II Study of the Combination of R-CHOP (RItuximab Plus Cyclophosphamide, Adriamycin, Vincristine, and Prednisolone) and Prophylactic Intrathecal Chemotherapy With Methotrexate in Patients With CD20+ Primary Breast Diffuse Large B-cell Lymphoma
Conditions
Interventions
Rituximab
Prophylactic intrathecal chemotherapy
Locations
1
South Korea
Chonbuk National University Hospital
Jeonju, South Korea
Start Date
August 1, 2011
Primary Completion Date
July 10, 2019
Completion Date
July 10, 2019
Last Updated
August 7, 2019
Lead Sponsor
Chonbuk National University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions